CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,940,385 | -36.2% | 170,211 | -27.8% | 0.02% | -41.7% |
| Q4 2022 | $6,178,379 | +9.4% | 235,816 | -17.9% | 0.04% | -2.7% |
| Q3 2022 | $5,648,000 | +167.0% | 287,284 | +137.5% | 0.04% | +184.6% |
| Q2 2022 | $2,115,000 | +394.2% | 120,942 | +362.5% | 0.01% | +550.0% |
| Q1 2022 | $428,000 | +29.3% | 26,147 | +29.0% | 0.00% | 0.0% |
| Q4 2021 | $331,000 | – | 20,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |